Home › Uterine Cancer › Texas › Fort Worth
Uterine Cancer clinical trials in Fort Worth, TX
3 studies for Uterine Cancer are looking for participants at sites in and around Fort Worth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
- Research Site, Fort Worth
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Texas Oncology, Fort Worth
About Uterine Cancer
Uterine cancer is a cancer that forms in tissues of the uterus. It is more likely to happen after menopause. There are things you can do that may help lower your risk.
More about Uterine Cancer on MedlinePlus
Uterine Cancer trials in other cities
- Houston, TX8 studies
- New York City, NY6 studies
- Columbus, OH6 studies
- Boston, MA5 studies
- Philadelphia, PA5 studies
- Austin, TX5 studies
- Miami, FL5 studies
- St. Louis, MO4 studies
- Orlando, FL4 studies
- Chicago, IL4 studies
- Pittsburgh, PA4 studies
- Nashville, TN4 studies
Other studies in Fort Worth
- Non-Small Cell Lung Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer12 studies
- Breast Cancer11 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Heart Failure7 studies
- Colorectal Cancer7 studies
- Triple-Negative Breast Cancer7 studies
- Metastatic Cancer7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Ulcerative Colitis7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.